{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:00:13Z","timestamp":1781712013441,"version":"3.54.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,9]]},"DOI":"10.7759\/cureus.94174","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:00:33Z","timestamp":1760000433000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Piperacillin-Induced Immune Thrombocytopenia: Diagnostic Challenges and Management"],"prefix":"10.7759","author":[{"given":"Arpeet","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuldeepsinh","family":"Atodaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew  C","family":"Rettew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niharika","family":"Kottapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratap","family":"Tetali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2018.1.576","article-title":"Drug-associated thrombocytopenia","volume":"2018","author":"Bakchoul T","year":"2018","unstructured":"Bakchoul T, Marini I. Drug-associated thrombocytopenia. Hematology Am Soc Hematol Educ Program. 2018, 2018:576-83. 10.1182\/asheducation-2018.1.576","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2013.05.005","article-title":"Approach to the diagnosis and management of drug-induced immune thrombocytopenia","volume":"27","author":"Arnold DM","year":"2013","unstructured":"Arnold DM, Nazi I, Warkentin TE, Smith JW, Toltl LJ, George JN, Kelton JG. Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev. 2013, 27:137-45. 10.1016\/j.tmrv.2013.05.005","journal-title":"Transfus Med Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03360.x","article-title":"Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management","volume":"7","author":"Aster RH","year":"2009","unstructured":"Aster RH, Curtis BR, McFarland JG, Bougie DW. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost. 2009, 7:911-8. 10.1111\/j.1538-7836.2009.03360.x","journal-title":"J Thromb Haemost"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200427150-00007","article-title":"Drug-induced immune thrombocytopenia","volume":"27","author":"van den Bemt PM","year":"2004","unstructured":"van den Bemt PM, Meyboom RH, Egberts AC. Drug-induced immune thrombocytopenia. Drug Saf. 2004, 27:1243-52. 10.2165\/00002018-200427150-00007","journal-title":"Drug Saf"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6109831","article-title":"Azithromycin-induced thrombocytopenia: a rare etiology of drug-induced immune thrombocytopenia","volume":"2019","author":"Butt MU","year":"2019","unstructured":"Butt MU, Jabri A, Elayi SC. Azithromycin-induced thrombocytopenia: a rare etiology of drug-induced immune thrombocytopenia. Case Rep Med. 2019, 2019:6109831. 10.1155\/2019\/6109831","journal-title":"Case Rep Med"},{"key":"ref6","article-title":"Occult quinine-induced thrombocytopenia","volume":"93","author":"Kojouri K","year":"2000","unstructured":"Kojouri K, Perdue JJ, Medina PJ, George JN. Occult quinine-induced thrombocytopenia. J Okla State Med Assoc. 2000, 93:519-21.","journal-title":"J Okla State Med Assoc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2012.1.191","article-title":"How to approach thrombocytopenia","volume":"2012","author":"Stasi R","year":"2012","unstructured":"Stasi R. How to approach thrombocytopenia. Hematology Am Soc Hematol Educ Program. 2012, 2012:191-7. 10.1182\/asheducation-2012.1.191","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072212","article-title":"Pathophysiology and diagnosis of drug-induced immune thrombocytopenia","volume":"9","author":"Vayne C","year":"2020","unstructured":"Vayne C, Gu\u00e9ry EA, Rollin J, Baglo T, Petermann R, Gruel Y. Pathophysiology and diagnosis of drug-induced immune thrombocytopenia. J Clin Med. 2020, 9:2212. 10.3390\/jcm9072212","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01852.x","article-title":"Serological studies of piperacillin antibodies","volume":"48","author":"Leger RM","year":"2008","unstructured":"Leger RM, Arndt PA, Garratty G. Serological studies of piperacillin antibodies. Transfusion. 2008, 48:2429-34. 10.1111\/j.1537-2995.2008.01852.x","journal-title":"Transfusion"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/hematolrep15020028","article-title":"A case of vancomycin-induced severe immune thrombocytopenia","volume":"15","author":"Shah S","year":"2023","unstructured":"Shah S, Sweeney R, Rai M, Shah D. A case of vancomycin-induced severe immune thrombocytopenia. Hematol Rep. 2023, 15:283-9. 10.3390\/hematolrep15020028","journal-title":"Hematol Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.21037\/aob-20-87","article-title":"Efficacy and mechanism of intravenous immunoglobulin treatment for immune thrombocytopenia in adults","volume":"6","author":"Almizraq RJ","year":"2021","unstructured":"Almizraq RJ, Branch DR. Efficacy and mechanism of intravenous immunoglobulin treatment for immune thrombocytopenia in adults. Ann Blood. 2021, 6:10.21037\/aob-20-87","journal-title":"Ann Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1592\/phco.20.4.292.34883","article-title":"Evaluation and management of drug-induced thrombocytopenia in the acutely ill patient","volume":"20","author":"Wazny LD","year":"2000","unstructured":"Wazny LD, Ariano RE. Evaluation and management of drug-induced thrombocytopenia in the acutely ill patient. Pharmacotherapy. 2000, 20:292-307. 10.1592\/phco.20.4.292.34883","journal-title":"Pharmacotherapy"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm6020016","article-title":"Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP)","volume":"6","author":"Zufferey A","year":"2017","unstructured":"Zufferey A, Kapur R, Semple JW. Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med. 2017, 6:16. 10.3390\/jcm6020016","journal-title":"J Clin Med"},{"key":"ref14","article-title":"Corticosteroid adverse effects","author":"Yasir M","year":"2025","unstructured":"Yasir M, Goyal A, Sonthalia S. Corticosteroid adverse effects. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/425505-a-case-of-piperacillin-induced-immune-thrombocytopenia-diagnostic-challenges-and-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:00:35Z","timestamp":1760000435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/425505-a-case-of-piperacillin-induced-immune-thrombocytopenia-diagnostic-challenges-and-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.94174","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,9]]}}}